ABSTRACT Objective: Many biologic agents cause some degree of immunosuppression. which can increase the risk of reactivation of tuberculosis infection (TBI). This risk is variable between individual biologics. We aimed to assess current (and recommended) clinical practice of TBI screening and treatment among patients initiating treatment with biologic agents. https://www.bekindtopets.com/top-super-Etatron-E128-Medicator-Pump-1-128-mega-choice/